Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2022
Invitae announces full access to Personalized Cancer Monitoring
Invitae announced full access to its Personalized Cancer Monitoring platform, which uses personalized tumor-informed assays to detect minimal or molecular residual disease in patients with solid tumors.
2020
Invitae appoints Kimber Lockhart to its board
Invitae appointed Kimber Lockhart to its board of directors, effective September 10, 2020.
2020
Invitae prices public stock offering
Invitae announced the pricing of an underwritten public offering of 17,777,778 shares of common stock at $9.00 per share. The offering was expected to close on or about April 6, 2020, subject to customary closing conditions.
2019
Invitae announces Invitae Discover research platform
Invitae announced the Invitae Discover clinical research platform, which uses biometric data available through Apple Watch. Its first study will investigate genetic causes of cardiovascular disease.